ClinicalTrials.Veeva

Menu

Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF)

Stanford University logo

Stanford University

Status

Withdrawn

Conditions

Primary Knee Replacement Surgery

Treatments

Device: Robotic exoskeleton device

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study involves an exoskeleton which is believed to increase quadriceps muscle strength in the rehabilitation phase after TKA and reduce the discharge the such patients in Extended care facility (ECF) . The purpose of this study is to access efficacy of the robotic exoskeleton device wrapped around the operated knee on patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  1. Patients undergoing unilateral primary knee replacement surgery
  2. Patients who pre-operatively desire discharged to ECF
  3. Patients willing and capable to sign the written informed consent

Exclusion criteria

  1. Patients undergoing bilateral primary knee replacement surgery
  2. Patients undergoing revision knee replacement surgery
  3. Patients who pre-operatively desire discharged to Home
  4. Patients not willing and capable to sign the written informed consent

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

robotic exoskeleton device
Experimental group
Description:
Patients who are scheduled to be discharged to a ECF will be asked if they would want to use the exoskeleton device ( for which safety and comfort has been established) instead of going for ECF.
Treatment:
Device: Robotic exoskeleton device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems